Riverwater Partners adds Lifeway Foods to portfolio amid record sales growth
Lifeway Foods reported $63 million in quarterly sales, a 37 per cent increase, as Riverwater Partners highlights the kefir producer’s dominant market position and expansion into adjacent categories.
Riverwater Partners, an investment management firm, has included Lifeway Foods in its Micro Opportunities Strategy portfolio, citing strong operational metrics and market dominance. The decision was detailed in the firm’s second quarter 2026 investor letter, which noted the addition occurred in April. Lifeway Foods, the largest producer and marketer of kefir in the United States, reported record quarterly sales of $63 million. This figure represents a 37 per cent increase driven primarily by volume growth rather than price adjustments.
The investment manager highlighted that gross margins expanded meaningfully during the period, supported by favourable milk costs. Additionally, Lifeway is progressing with a major plant expansion, which remains on track for completion by the end of the year. Riverwater described the company as the first to introduce kefir to U.S. consumers on a commercial scale, noting its exclusive blend of 12 live and active probiotics across a product range that includes traditional, organic, grass-fed, lactose-free, and collagen-added variations.
Lifeway Foods is also extending its brand presence into adjacent categories to diversify revenue streams. The company has introduced Probugs kefir pouches for children, farmer cheese, and a high-protein and creatine line. Further diversification efforts include a new probiotic butter and a licensing agreement for probiotic dog kibble under the Open Farm brand. These moves underscore the company’s strategy to leverage its core probiotic expertise across broader consumer goods.
As of July 23, 2026, Lifeway Foods shares closed at $30.33, reflecting a market capitalisation of $463.5 million. The stock posted a one-month return of 3.20 per cent and a 52-week gain of 14.58 per cent. Despite the positive absolute result for the Micro Opportunities Strategy in the second quarter, Riverwater noted that the fund underperformed the Russell Microcap Index. The benchmark benefited from a speculative rally in micro-cap stocks driven by an accelerating artificial intelligence buildout and geopolitical supply shocks.
Riverwater Partners maintained a disciplined approach, focusing on profitable, well-managed small businesses at reasonable prices rather than chasing fleeting market trends. While the firm acknowledged the potential of Lifeway Foods, it noted that hedge fund interest in the stock had slightly declined, with 14 portfolios holding the shares at the end of the first quarter, down from 17 in the previous quarter. The manager stated that while Lifeway has merit, certain artificial intelligence stocks currently offer greater upside potential with less downside risk.
